Evotec insomnia treatment shows promise
The proof-of-principle clinical trial in healthy volunteers was intended to test the hypothesis that the compound has potential as a novel medicine for the treatment of insomnia. The
The proof-of-principle clinical trial in healthy volunteers was intended to test the hypothesis that the compound has potential as a novel medicine for the treatment of insomnia. The
NeurotrophinCell (NtCell) is Living Cell’s injectable live cell product being developed for the treatment of patients with neurodegenerative diseases. NtCell is manufactured using natural porcine cells that are
These ion channels act like electrical wires and permit embryonic stem cells (ESCs), versatile cells that possess the unique ability to become all cell types of the body,
In particular, Generex has announced that the president of Antigen Express, Eric von Hofe, will focus his efforts and those of the company on bringing this new vaccine
“More than 1,300 patients in the US and Mexico are now participating in our phase III ADT trial. We are on track to have final data from this
Based on preclinical study data, Sepracor believes that SEP-225289 has the potential to be a leading drug candidate in the newly emerging field of triple reuptake inhibitors (TUIs).
Ulcerative colitis is one of multiple indications including rheumatoid arthritis, psoriasis, and Crohn’s disease, in which Remicade is either approved or in late stage development. A pooled analysis
The results published in The New England Journal of Medicine were described in the journal as “simply stunning” by Gabriel Hortobagyi of the University of Texas MD Anderson
This expanded indication will allow healthcare practitioners to vaccinate younger children against hepatitis A with Havrix and may help to further reduce the incidence of hepatitis A in
The analysis of the data suggested that the combination of the two drugs was no more effective in treating the disease than the use of Avastin on its